In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lauren Nardella

Lauren Nardella has been with The Rose Sheet for six years, covering the regulation, business, science and policy of the cosmetics and personal-care products industries. She enjoys tackling complex issues impacting the cosmetics world and turning them into stories that help The Rose Sheet’s readership stay abreast of current topics. Nardella has more than a decade of experience in journalism, and was previously a business reporter for various daily newspapers. She lives in Northern Virginia.
Set Alert for Articles By Lauren Nardella

Latest From Lauren Nardella

Coty ‘Absolutely Not In Fire Sale Mode’ Following Younique Divestiture That ‘Stunned’ Investors

Leadership assured analysts on 6 November that Coty's Professional Beauty and Brazilian businesses are strong performers of high interest to potential acquirers, unlike Younique. Coty recently sold its majority stake in the social selling company back to its founders at a price that raised eyebrows.

Beauty Business Strategies

FDA, PCPC To Meet On Sunscreen Work Plan; Industry’s ‘Extended’ Study Timelines A Possible Topic

The US FDA’s deferral of final GRASE rulemaking on UV filters identified in its February proposed rule as lacking data hinges on its acceptance of industry’s work plan. In October, the agency expressed concerns about the plan submitted by the Personal Care Products Council, but granted the group’s request for a meeting – slated for 13 November – to discuss the issues further.

United States FDA

National Toxicology Program: Oxybenzone Shows ‘Equivocal Evidence Of Carcinogenic Activity’

A National Toxicology Program rat study linking oxybenzone to “equivocal evidence of carcinogenic activity” is far from damning, but it's a reminder of just how steep a mountain industry may have to climb to maintain the UV filter’s generally recognized as safe and effective (GRASE) status for OTC marketability, currently under FDA review.

United States Regulation

Oxybenzone Sunscreen Remains Live Issue As Florida Lawmakers Lay Groundwork For 2020

Florida's legislature does not reconvene until mid-January 2020, but interim committee meetings are in progress and a proposed bill to ban non-prescription sales of oxybenzone/octinoxate-containing sunscreens already has been filed for consideration in the next session.

State News Legislation

Essential Oils Off EU Imports Tariff List In Trade War Win For Fragrance Creators

Essential oils no longer on list of products slated for EU tariff increases effective 18 October, a win for US fragrance industry facing uncertainty in tumultuous global trade climate. Fragrancy industry, like dietary supplement manufacturers, still face higher tariffs on imports from China as next round of hikes is scheduled to start 15 October.

Cosmetics Trade

Schakowsky’s Loaded Cosmetics Bill Described As ‘Floor, Not A Ceiling’ For States To Build On

The Safe Cosmetics and Personal Care Products Act, reintroduced in the US House, exceeds the proposed Personal Care Products Safety Act in the Senate in terms of the duties and resource demands it would impose on companies and the FDA, while leaving states free to regulate cosmetics even more stringently. The proposal now must vie for the attention of the Energy and Commerce Committee.

Beauty United States
See All
UsernamePublicRestriction

Register